Integrated analysis of single cell‐RNA sequencing and Mendelian randomization identifies lactate dehydrogenase B as a target of melatonin in ischemic stroke
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14741 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Fei Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurovascular Intervention and Neurosurgery, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, Chi…. Hauptthemen laut MEDLINE: Ischemic Stroke, L-Lactate Dehydrogenase, Melatonin, Mendelian Randomization Analysis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Cross Research Fund of Medicine and Engineering of Shanghai Jiaotong University, The Project of Key Medical Discipline Group Construction in Shanghai Pudong New Area.
Themen: Schlaganfall
Abstract (Originalsprache)
Aims
Despite the success of single‐cell RNA sequencing in identifying cellular heterogeneity in ischemic stroke, clarifying the mechanisms underlying these associations of differently expressed genes remains challenging. Several studies that integrate gene expression and gene expression quantitative trait loci (eQTLs) with genome wide‐association study (GWAS) data to determine their causal role have been proposed.
Methods
Here, we combined Mendelian randomization (MR) framework and single cell (sc) RNA sequencing to study how differently expressed genes (DEGs) mediating the effect of gene expression on ischemic stroke. The hub gene was further validated in the in vitro model.
Results
We identified 2339 DEGs in 10 cell clusters. Among these DEGs, 58 genes were associated with the risk of ischemic stroke. After external validation with eQTL dataset, lactate dehydrogenase B (LDHB) is identified to be positively associated with ischemic stroke. The expression of LDHB has also been validated in sc RNA‐seq with dominant expression in microglia and astrocytes, and melatonin is able to reduce the LDHB expression and activity in vitro ischemic models.
Conclusion
Our study identifies LDHB as a novel biomarker for ischemic stroke via combining the sc RNA‐seq and MR analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurovascular Intervention and Neurosurgery, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.
- Department of Neurology, Shanghai Pudong New area People's Hospital, Shanghai, China.
- Department of Neurology, Shanghai Ninth People's Hospital, Shanghai, China.
- Department of Neurosurgery, Shanghai Pudong New area People's Hospital, Shanghai, China.
ORCID-Profile: Fei Shi, Ping Zheng
Förderung
- the Cross Research Fund of Medicine and Engineering of Shanghai Jiaotong University
- The Project of Key Medical Discipline Group Construction in Shanghai Pudong New Area
Zitieren
APA
Shi, F., Zhang, G., Li, J., Shu, L., Yu, C., Ren, D., Zhang, Y., & Zheng, P. (2024). Integrated analysis of single cell‐RNA sequencing and Mendelian randomization identifies lactate dehydrogenase B as a target of melatonin in ischemic stroke. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14741
Vancouver
Shi F, Zhang G, Li J, Shu L, Yu C, Ren D, et al. Integrated analysis of single cell‐RNA sequencing and Mendelian randomization identifies lactate dehydrogenase B as a target of melatonin in ischemic stroke. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14741
BibTeX
@article{Shi2024,
author = {Shi, Fei and Zhang, Guiyun and Li, Jinshi and Shu, Liang and Yu, Cong and Ren, Dabin and Zhang, Yisong and Zheng, Ping},
title = {Integrated analysis of single cell‐RNA sequencing and Mendelian randomization identifies lactate dehydrogenase B as a target of melatonin in ischemic stroke},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14741}
}
EUVIMED